advertising
-
1
Ramsey SD, Newton K, Blough D, et al: Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22: 382, 1999.
-
2
Lavery LA, Peters EJ, Armstrong DG, et al: Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Res Clin Pract 83: 347, 2009.
-
3
Centers for Disease Control and Prevention: Hospital discharge rates for nontraumatic lower extremity amputation per 1,000 diabetic population, by age, United States, 1988–2009. Available at: http://www.cdc.gov/diabetes/statistics/lea/fig4.htm.
-
4
Gu Y, Kokar C, Gooday C, et al: A 5-year follow-up study to assess clinical outcomes of patients with diabetes undergoing lower limb angiography for significant peripheral artery disease. Diabetes Ther 6: 481, 2015.
-
5
Van Damme H, Rorive M, Martens De Noorthout BM, et al: Amputations in diabetic patients: a plea for footsparing surgery. Acta Chir Belg 101: 123, 2001.
-
6
Malhotra R, Chan CS, Nather A: Osteomyelitis in the diabetic foot. Diabet Foot Ankle July: 5, 2014.
-
7
Uckay I, Aragon-Sanchez J, Lew D, et al: Diabetic foot infections: what have we learned in the last 30 years? Int J Infect Dis 40: 81, 2015.
-
8
Lipsky BA, Berendt AR, Cornia PB, et al: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 54: e132, 2012.
-
9
Young H, Knepper B, Hernandez W, et al: Pseudomonas aeruginosa: an uncommon cause of diabetic foot infection. JAPMA 105: 125, 2015.
-
10
Charles PG, Uckay I, Kressmann B, et al: The role of anaerobes in diabetic foot infections. Anaerobe 34: 8, 2015.
-
11
Lipsky BA, Aragon-Sanchez J, Diggle M, et al: IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev 32(suppl 1): 45, 2016.
-
12
Beieler AM, Jenkins TC, Price CS, et al: Successful limb-sparing treatment strategy for diabetic foot osteomyelitis. JAPMA 102: 273, 2012.
-
13
Centers for Disease Control and Prevention: CDC/NHSN surveillance definitions for specific types of infections. Available at: http://www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef_current.pdf.
-
14
Hennion DR, Siano KA: Diagnosis and treatment of peripheral arterial disease. Am Fam Physician 88: 306, 2013.
-
15
Ackroyd SA, Wexler DJ: Effectiveness of diabetes interventions in the patient-centered medical home. Curr Diabetes Rep 14: 471, 2014.
-
16
Maeng DD, Graf TR, Davis DE, et al: Can a patient-centered medical home lead to better patient outcomes? the quality implications of Geisinger's ProvenHealth Navigator. Am J Med Qual 27: 210, 2012.
-
17
Saltoglu N, Yemisen M, Ergonul O, et al: Predictors for limb loss among patient with diabetic foot infections: an observational retrospective multicentric study in Turkey. Clin Microbiol Infect 21: 659, 2015.
-
18
Hinchliffe RJ, Brownrigg JR, Andros G, et al: Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review. Diabetes Metab Res Rev 32(suppl 1): 136, 2016.
-
19
Blume P, Salonga C, Garbalosa J, et al: Predictors for the healing of transmetatarsal amputations: retrospective study of 91 amputations. Vascular 15: 126, 2007.
-
20
Nguyen TH, Gordon IL, Whalen D, et al: Transmetatarsal amputation: predictors of healing. Am Surg 72: 973, 2006.
-
21
Landry GJ, Silverman DA, Liem TK, et al: Predictors of healing and functional outcome following transmetatarsal amputations. Arch Surg 146: 1005, 2011.
-
22
Atway S, Nerone VS, Springer KD, et al: Rate of residual osteomyelitis after partial foot amputation in diabetic patients: a standardized method for evaluating bone margins with intraoperative culture. J Foot Ankle Surg 51: 749, 2012.
-
23
Ulcay A, Karakas A, Mutluoglu M, et al: Antibiotherapy with and without bone debridement in diabetic foot osteomyelitis: a retrospective cohort study. Pak J Med Sci 30: 28, 2014.
-
24
Zeun P, Gooday C, Nunney I, et al: Predictors of outcomes in diabetic foot osteomyelitis treated initially with conservative (nonsurgical) medical management: a retrospective study. Int J Low Extrem Wounds 15: 19, 2016.
-
25
Lazaro-Martinez JL, Aragon-Sanchez J, Garcia-Morales E: Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial. Diabetes Care 37: 789, 2014.
-
26
Lipsky BA, Sheehan P, Armstrong DG, et al: Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial. Int Wound J 4: 30, 2007.
Risk Factors for Below-the-Knee Amputation in Diabetic Foot Osteomyelitis After Minor Amputation
Search for other papers by Whitney Miller in
Current site
Google Scholar
PubMed
Search for other papers by Chrystal Berg in
Current site
Google Scholar
PubMed
Search for other papers by Michael L. Wilson in
Current site
Google Scholar
PubMed
Search for other papers by Susan Heard in
Current site
Google Scholar
PubMed
Search for other papers by Bryan Knepper in
Current site
Google Scholar
PubMed
Search for other papers by Heather Young in
Current site
Google Scholar
PubMed
Background:
Below-the-knee amputation (BKA) can be a detrimental outcome of diabetic foot osteomyelitis (DFO). Ideal treatment of DFO is controversial, but studies suggest minor amputation reduces the risk of BKA. We evaluated risk factors for BKA after minor amputation for DFO.
Methods:
This is a retrospective cohort of patients discharged from Denver Health Medical Center from February 1, 2012, through December 31, 2014. Patients who underwent minor amputation for diagnosis of DFO were eligible for inclusion. The outcome evaluated was BKA in the 6 months after minor amputation.
Results:
Of 153 episodes with DFO that met the study criteria, 11 (7%) had BKA. Failure to heal surgical incision at 3 months (P < .001) and transmetatarsal amputation (P = .009) were associated with BKA in the 6 months after minor amputation. Peripheral vascular disease was associated with failure to heal but not with BKA (P = .009). Severe infection, bacteremia, hemoglobin A1c, and positive histopathologic margins of bone and soft tissue were not associated with BKA. The median antibiotic duration was 42 days for positive histopathologic bone resection margin (interquartile range, 32–47 days) and 16 days for negative margin (interquartile range, 8–29 days). Longer duration of antibiotics was not associated with lower risk of BKA.
Conclusions:
Patients who fail to heal amputation sites in 3 months or who have transmetatarsal amputation are at increased risk for BKA. Future studies should evaluate the impact of aggressive wound care or whether failure to heal is a marker of another variable.
advertising
advertising
